Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
WhiteOak Capital Pharma and Healthcare Fund vs SBI Healthcare Opportunities Fund
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
27 companies both funds hold · largest common part first
Only in A
23 companies · largest first
- IPCA Laboratories Limited3.17%
- Zydus Lifesciences Limited3.10%
- Neuland Laboratories Limited2.86%
- Thyrocare Technologies Limited2.51%
- Shaily Engineering Plastics Limited2.02%
- Narayana Hrudayalaya Ltd.1.78%
- Vijaya Diagnostic Centre Limited1.72%
- Onesource Specialty Pharma Limited1.71%
- Navin Fluorine International Limited1.56%
- Aarti Pharmalabs Limited1.33%
- Procter & Gamble Health Limited1.30%
- Molbio Diagnostics Limited1.27%
- Piramal Pharma Limited1.17%
- Kovai Medical Center & Hospital Limited1.05%
- Senores Pharmaceuticals Limited0.89%
And 8 more.
Only in B
8 companies · largest first
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 85.1% | 87.9% | -2.85 pp |
| Chemicals | 3.2% | 5.2% | -1.98 pp |
| Consumer Durables | 2.0% | 0.0% | +2.02 pp |
| Not classified | 9.7% | 6.9% | +2.81 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →